Some studies showed good results after combined therapies (transarterial chemoembolization plus RFA) in hepatocellular carcinoma and liver mets from CRC. We have in selected patients with large tumors who achieved great reductions in the contrast-enhanced areas, and some of them changed their tumor grading.